OTC · CIK 0000822370
EMMA Emmaus Life Sciences, Inc.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $0.04 on Oct 9, 2026, +410% from the 52-week low and -48% from the high.
Emmaus Life Sciences, Inc. (EMMA) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on Sep 2, 2026. In the last 90 days insiders made 1 open-market buy worth $18k and 0 open-market sells worth $0, net +$18k.
1 open-market trade has been scored at EMMA. The newest: Willis C Lee (CEO) bought $18k of stock on May 30, 2025, filed Sep 2, 2026, scored 35 (weak).
EMMA closed at $0.04 on Oct 9, 2026, 410% above its 52-week low and 48% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Emmaus Life Sciences, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Willis C Lee CEO buy | $18k 530,767 shares | +333% | - |
Transactions
Every row filed, 6 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +70,000 | $0.02 | $1,400 | 229,400 | 41 d ago |
| Aug 29, 2025 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +170,000 | $0.01 | $1,700 | 275,400 | 41 d ago |
| Aug 25, 2026 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +46,000 | $0.04 | $1,840 | 445,400 | 41 d ago |
| Aug 27, 2026 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +50,000 | $0.05 | $2,500 | 495,400 | 41 d ago |
| Aug 28, 2026 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +94,767 | $0.06 | $5,686 | 590,167 | 41 d ago |
| Aug 31, 2026 | Willis C Lee CEO | POpen-market purchase Common stock, $0.001 par valueindirect: Fidelity Roth IRA FBO Willis C. Lee | +100,000 | $0.05 | $5,000 | 690,167 | 41 d ago |
Questions about EMMA
Answered from the filings on this page, as of the latest one.
Are insiders buying EMMA?
As of Sep 2, 2026, SEC Form 4 filings show 1 open-market buy worth $18k by 1 insider and 0 open-market sells worth $0 by 0 insiders at Emmaus Life Sciences, Inc. in the last 90 days, net +$18k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade EMMA on the open market?
Willis C Lee (CEO) bought $18k of EMMA on May 30, 2025 and filed the Form 4 on Sep 2, 2026. InsiderTell scored 35 (weak).
How many insiders file Form 4 at Emmaus Life Sciences, Inc.?
1 person has filed a Form 4 at Emmaus Life Sciences, Inc., among them Willis C Lee (CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.